Digital Pathology Market 2020 Analysis Research and Development Forecast by 2025
New York, June 25, 2020: Inside the modern day method, the glass slides containing specimen
samples are transformed into clean viewing, analysis, storage, and control of the amassed
information. This is enabled in element with the aid of virtual microscopy, a generation that
permits a success photograph posting and transmission over a related network. The records
wealthy photograph bureaucracy the bottom for upkeep of digital health statistics of the
affected person population and compile the allotted facts to build a principal database. The
advancements in virtual pathology are expected to take the conventional pathology to a
greater advanced stage. Digitalization of pathology has led to the automation of the exams at
some point of prognosis, hence saving fee and efforts.
The Global Digital Pathology Market is expected to exceed more than US$ 1300 million by 2024
and will grow at a CAGR of more than 12% in the given forecast period.
Browse Full Report: https://www.marketresearchengine.com/reportdetails/digital-
The report covers detailed competitive outlook including the market share and company
profiles of the key participants operating in the global market. Key players profiled in the report
include Visiopharm, Indica Labs, Digipath Inc., Koninklinje Philips N. V., Hamamatsu Photonics K.
K., PerkinElmer, Inc., Danaher Corporation (Leica Microsystem), Nikon Corporation, Pixcelldata
Ltd., Glencoe Software Inc., and Definiens AG.. Company profile includes assign such as
company summary, financial summary, business strategy and planning, SWOT analysis and
The digital pathology market is segmented on the lines of its product, end user and regional.
Based on product segmentation it covers whole slide imaging, information management system
storage and communication, image analysis informatics and others. Under end user
segmentation it covers hospitals and diagnostic centers